Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nexium

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

AZ adds gout drug Zurampic to asset sale

AZ adds gout drug Zurampic to asset sale The deal gives AZ another cash injection as it weathers the loss of blockbuster brands such as cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal diseases and brings new pipeline

AZ offloads more products in slimming drive

AZ offloads more products in slimming drive years, including cholesterol drug Crestor (rosuvastatin) and Nexium (esomeprazole) for gastrointestinal indications.

AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy

AZ boosts cardio-renal portfolio with $2.7bn ZS Pharma buy The UK firm has just announced its third-quarter results, which saw sales slip 10% to $5.9bn mainly as a result of generic competition to gastrointestinal drug Nexium (esomeprazole) which

AZ gets injunction to protect Pulmicort Respules

AZ gets injunction to protect Pulmicort Respules The early onset of generic competition would exacerbate a tricky period for AZ, which lost patent protection for gastrointestinal therapy Nexium (esomeprazole) in a number of markets including the US - prompting

Teva’s generic Nexium wins US approval

Teva’s generic Nexium wins US approval FDA backs copy of AstraZeneca’s heartburn drug. Teva is set to be the first company to market a generic version of AstraZeneca's blockbuster severe heartburn treatment Nexium in the ... Teva is now set to take advantage of what looks to be an exclusive

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics